BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7521739)

  • 1. The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways.
    Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; de Waal RM
    Transpl Immunol; 1993; 1(3):183-91. PubMed ID: 7521739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
    Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
    Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
    Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
    Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling.
    Wingren AG; Dahlenborg K; Björklund M; Hedlund G; Kalland T; Sjögren HO; Ljungdahl A; Olsson T; Ekre HP; Sansom D
    J Immunol; 1993 Aug; 151(3):1328-36. PubMed ID: 7687629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.
    Chong AS; Jiang XL; Scuderi P; Lamas M; Graf LH
    Cancer Immunol Immunother; 1994 Aug; 39(2):127-34. PubMed ID: 7519126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins.
    Mittrücker HW; Fleischer B
    Cell Immunol; 1992 Jan; 139(1):108-17. PubMed ID: 1370253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.
    Chong AS; Staren ED; Scuderi P
    Cancer Immunol Immunother; 1992; 35(5):335-41. PubMed ID: 1382856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
    Ferrini S; Sforzini S; Cambiaggi A; Poggi A; Meazza R; Canevari S; Colnaghi MI; Moretta L
    Int J Cancer; 1994 Mar; 56(6):846-52. PubMed ID: 7907079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cells promote anti-CD3-induced T-cell proliferation via cell-cell contact mediated by LFA-1 and CD2.
    Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; De Waal RM
    Scand J Immunol; 1993 Nov; 38(5):435-44. PubMed ID: 7901894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
    Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
    Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
    Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 4 and tumour necrosis factor alpha induce different adhesion pathways in endothelial cells for the binding of peripheral blood lymphocytes.
    Galéa P; Lebranchu Y; Thibault G; Bardos P
    Scand J Immunol; 1992 Oct; 36(4):575-85. PubMed ID: 1384114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
    Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
    J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymocyte LFA-1 and thymic epithelial cell ICAM-1 molecules mediate binding of activated human thymocytes to thymic epithelial cells.
    Singer KH; Denning SM; Whichard LP; Haynes BF
    J Immunol; 1990 Apr; 144(8):2931-9. PubMed ID: 1691223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions.
    Shimizu Y; Newman W; Gopal TV; Horgan KJ; Graber N; Beall LD; van Seventer GA; Shaw S
    J Cell Biol; 1991 Jun; 113(5):1203-12. PubMed ID: 1710227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LFA-3 adhesion pathway is differently utilized by superantigen-activated human CD4+ T-cell subsets.
    Gjörloff A; Hedlund G; Kalland T; Sansom D; Fischer H; Trowsdale J; Sjögren HO; Dohlsten M
    Scand J Immunol; 1992 Aug; 36(2):243-50. PubMed ID: 1380180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T cells to cultured endothelial cells. Indication for a new adhesion pathway.
    Vennegoor CJ; van de Wiel-van Kemenade E; Huijbens RJ; Sanchez-Madrid F; Melief CJ; Figdor CG
    J Immunol; 1992 Feb; 148(4):1093-101. PubMed ID: 1371131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction.
    Hughes CC; Savage CO; Pober JS
    J Exp Med; 1990 May; 171(5):1453-67. PubMed ID: 1692079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.